Innovation in myeloma treatments PARP excellence!

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

In this issue of Blood, Neri and colleagues report a promising treatment of myeloma using a combination of bortezomib plus inhibition of the enzyme PARP1 (REF). 1This is welcome news, as new avenues for the treatment of the disease are needed.

Original languageEnglish (US)
Pages (from-to)6234-6235
Number of pages2
JournalBlood
Volume118
Issue number24
DOIs
StatePublished - Dec 8 2011

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this